FCAAP Member Resources

FCAAP Resources

FCAAP is always looking for resources to help you in your practice of pediatrics. These links have been carefully curated to help you stay informed about the latest resources, tools, and medical guidance. Looking for education opportunies? Take a look at our CE Opportunities page!

Not a member of FCAAP? Learn more about the Chapter, check out some of our exclusive Member Benefits, and join today.

COVID-19 Provider Resources

Below are key resource materials for providers on the Coronavirus Disease 2019 (COVID-19) pandemic.

ANNOUNCEMENTS

This announcements section will be updated in conjunction with the release of pertinent information from leading agencies.

FCAAP Statement on the COVID-19 Vaccination for Children

In response to the March 7, 2022 announcement by Florida’s Surgeon General that the Florida Department of Health will not recommend COVID-19 vaccination for “healthy children,” FCAAP has released a statement reaffirming its recommendation that all eligible children 5 years of age and older receive the vaccine. Read the statement here.

Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus (RSV) Vaccine Candidate for the Prevention of RSV in Infants from Birth up to Six Months of Age by Active Immunization of Pregnant Women: Read the News Release h PDF

Caring for Children With Special Health Care Needs, COVID-19 Testing

The AAP has updated some interim guidance during COVID-19. The guidance for the care of children with special health care needs notes that some adolescents who are immunocompromised may be eligible for an additional primary series dose of the vaccine, and all who are eligible are urged to get a booster dose for additional protection. It also emphasizes that cloth face masks are less effective against the omicron variant, and the best protection is given by well-fitting N95/K95/KF94 masks, followed by well-fitting surgical/procedure masks. The testing updates include alignment and linking to CDC K-12 guidance and quarantine and isolation guidance.

Updated Interim Guidance: Caring for Children and Youth With Special Health Care Needs During the COVID-19 Pandemic
Updated Interim Guidance: COVID-19 Testing Guidance

American Academy of Pediatrics Offers New Masking Recommendations for Families Following Updated CDC Guidance

CDC’s updated recommendations allow communities to relax risk mitigation measures like masking when all three of the following conditions are met: low COVID-19 transmission rates, low hospital admission rates, and adequate hospital capacity. Communities with high levels of immunization also have more protections that make masks less critical, though many children and individuals lack this protection.

AAP advises families to consider the following factors in making this decision:

  • If their child is between ages 2 and 5 and currently ineligible for COVID-19 vaccine
  • If their child is immunocompromised and may not have a protective immune response to the COVID-19 vaccine, or is at high risk for severe COVID-19 illness
  • If their child is not immunized
  • If other members of their family are at higher risk of severe disease or are not immunized
  • If they live in a community with “high” COVID-19 transmission

These factors may lead adults and children to continue wearing face masks in public indoor settings, including schools, even if not required. According to the AAP, children, adolescents, and teachers who choose to continue wearing face masks in school settings should be supported in their decision to do so.

CDC’s guidance calls for public health decision-making on masks based on local conditions. Based on CDC’s new guidance, universal mask policies are still necessary in many parts of the country. In addition, localities will need flexibility to reinstitute masking as local situations warrant. Policies that serve as impediments to this local decision-making are inappropriate and should be eliminated.

The AAP strongly recommends that all individuals ages 5 years and older receive the COVID-19 vaccine. Additional layered prevention strategies such as testing, ventilation, and masking can also create a cocooning effect that offers protection for children too young to be vaccinated or who have health conditions, such as immune-compromise or lung conditions, that are more likely to result in severe disease from COVID-19 infection.

Pfizer Medical Now Providing COVID Vaccine Training for kids 6 months though 4 years

Pfizer Medical is now conducting virtual training, available to all providers, on potential new presentation (Maroon Cap) for individuals 6 months through 4 years of age. Please note, the vaccine has NOT been authorized or approved for use in individuals younger than 5 years of age in the United States. The US Government has, however, requested that Pfizer immediately begin training providers on the Maroon Cap presentation of the vaccine for patients 6 months through 4 years of age. These sessions will be updated to reflect the latest information and recent changes, which will be identified at the start of each session.

Update, March 16, 2022

Pfizer’s medical updates & immunization site training has been revamped and the program was divided into two sections:

  1. Medical updates & new information, followed by:
  2. Storage, handling, and administration of the vaccine.

Please visit this page for more information and the most up-to-date training schedule.

CDC/IDSA COVID-19 Clinician Call: Vaccine Boosters

These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues.

FCAAP RESOURCES

AMERICAN ACADEMY OF PEDIATRICS (AAP) RESOURCES

AAP offers information to help practices administer COVID-19 vaccine to children and teens. These pages will be updated frequently as details are available regarding dosing, coding, and administration of the vaccine for ages 5-11. For questions or comments related to the vaccine, please email COVID-19@aap.org.

AGENCIES

Agency for Health Care Administration (AHCA):\

Centers for Disease Control and Prevention (CDC)

Centers for Medicare & Medicaid Services (CMS)

County Executive Orders on Facial Coverings During COVID-19

Available executive orders pertaining to facial coverings during the COVID-19 pandemic in Florida can be found alphabetically by county as follows: Alachua, Broward, Gadsden, Hillsborough, Leon, Martin, Miami-Dade, Monroe, Orange, Osceola, Palm Beach, Pasco, Pinellas, and the City of Tampa.

Florida Department of Health (FL DOH)

Florida Division of Emergency Management

Florida Healthy Kids

National Committee for Quality Assurance (NCQA)

State of Florida Response

USDA Food & Nutrition Service

U.S. Food & Drug Administration (FDA)

  • FDA Updated EUA for Phizer COVID-19 Vaccine – The U.S. Food and Drug Administration has authorized storage of Pfizer Inc and German partner BioNTech SE’s COVID-19 vaccine at standard freezer temperatures for up to one month. Unopened, thawed vials of the vaccine can be stored in a refrigerator at 2 to 8 degrees Celsius for up to a month, up from a previous maximum limit of five days. Review the full EUA amendment and access the Fact Sheet.
  • FDA: Multilingual COVID-19 Resources

White House Task Force COVID-19 Response

BUSINESS & PERSONAL RESOURCES

FINANCIAL RELIEF

TELEHEALTH

Disclaimer: The information above is subject to change daily, individual contracts may vary, and the 30-90 day periods for waivers will vary between payors.

The information provided on this page is subject to change without notice based upon new information, resources, and directives from federal, state, and local authorities and medical experts. While FCAAP will do its best to update information that has been changed due to the issuance of new guidance and directives, there will be a delay in such updates and we cannot guarantee that all information will be updated to reflect such changes. This information is provided only as general guidance and is not being offered as a medical or legal opinion.Thank you to The Pfizer Foundation for supporting FCAAP’s efforts to support pediatricians and families during the COVID-19 pandemic.

Immunizations

Atlantic Health Partners has always been a strong resource for our members’ immunization efforts by offering the most favorable vaccine prices, terms, and purchasing support. We are pleased to share that Atlantic Health Partners has expanded its program with the addition of GlaxoSmithKline (GSK) vaccines. This include options for practices interested in the GSK portfolio or for those practices just interested in using Bexsero (Meningitis B vaccine).

Atlantic Health Partners now offers our members the full array of vaccine options to best meet your individual practice needs including:

  • Most favorable pricing for Sanofi, Merck, GSK, and Dynavax vaccines
  • A comprehensive flu program that includes Sanofi, GSK, and Seqirus products
  • Meningoccocal B vaccine options that include both Trumenba or Bexsero
  • No minimum quantity requirements to always receive most favorable pricing and terms
  • Excellent and timely customer service including reimbursement support and advocacy

For information about the program, please contact Jeff or Cindy at 800-741-2044 or info@atlantichealthpartners.com

Practice Resources

Medicaid and MPIP

Prescriptions

NON-OPOID PAIN MANAGEMENT

  • Your responsibility under the law. (FDOH)

Public Charge & Immigrant Child Health Resources

The public charge rule goes into effect on February 24, 2020.

Social Media

BABY FORMULA SHORTAGE PROVIDER RESOURCES

FCAAP is happy to provide you a convenient set of provider resource links to help you navigate the nationwide baby formula shortage.

simply healthy minds
ElseNutrition

Questions about FCAAP membership?

Contact Anayra Barreras Pena, Membership Coordinator at 850-224-3939 ext. 1002, or send a message.